中国药师-专业站 - 近期刊登

HPLC法测定血浆中非诺贝特活性代谢物非诺贝酸的浓度-07.6

阅读: 时间: 2007-6-15 16:06:00

徐帆  冯恩富  余昉  (成都军区昆明总医院  昆明 650032)

摘  要  目的:建立高效液相色谱法测定血浆中非诺贝特活性代谢产物非诺贝特酸浓度。方法:以甲醇直接沉淀血浆蛋白, 色谱柱为Waters sunfire C18柱(150 mm×4.6 mm,5 μm),流动相为0.05 mol•L-1磷酸二氢钾溶液-甲醇(70∶30),用磷酸调pH2.5,检测波长286 nm。结果:非诺贝酸的保留时间约为6.7 min,线性范围为0.2~20.0 μg•ml-1 ( r=0. 999 9),最低定量限为0.2 μg•ml-1,方法回收率99.28%~101.38%,提取回收率 97.18%~107.28%,日内和日间RSD均小于10%。结论:本法简便、快捷、灵敏,适用于非诺贝特药物动力学研究。

关键词  非诺贝特; 非诺贝特酸; 高效液相色谱法; 药动学

中图分类号:R939.1

文献标识码:A

文章编号:1008-049X(2007)06-0530-03

Determination of Bioactive Metabolite Fenofibric Acid of Fenofibrate in Human Plasma by HPLC

Xu Fan, Feng Enfu,YU Fang(Kunming General Hospital of Chengdu Military Region, Yunnan, Kunming 650032,China)


ABSTRACT  Objective: To establish an HPLC method to determine the concentration of bioactive metabolite fenofibric acid offenofibrate. Method: Plasma protein was precipitated by methanol; Waters sunfire C18 column(150 mm×4.6 mm,5 μm) was used; the mobile phase  was0.05 mol•L-1,potassium dihydrogen phosphatemethanol(70∶30, adjust pH to 2.5 with phosphoric acid).The detection wavelength was  at 288 nm. Result: The retention time of fenofibric acid was 6.7 minute. The limit of quantitation for fenofibric acid was 0.2 μg•ml-1.RSDsmaller than 20%.It was well linearity in the range from 0.2 μg•ml-1to 20.0μg•ml-1. Conclusion: The method  was convenient,fast and sensitive.

KEY WORDS  Fenofibrate;Fenofibric acid;HPLC;Pharmacokinetics

参  考  文  献

1 范国荣,林梅,张正行,等.人血浆中非诺贝特活性代谢物非诺贝酸的高效液相色谱法测定[J].药物分析杂志,2000,20(4):231-234
2 戴敏,裘福荣,陈波,等.国产微粉化非诺贝特分散片的相对生物利用度研究[J].中国临床药理学杂志,2002,18(4):287-289
3 Streel B, Hubert pH, Ceccato A. Determination of fenofibric acid in human plasma using automated solidphase extraction coupled to liquid chromatography[J]. Journal of Chromatography B, 2000,742:391-400
4 Lucas DM, Luis AC, Ricardo HR, et al. Determination of bezafibrate, ciprofibrate and fenofibric acid in human plasma by highperformance liquid chromatography[J]. Journal of Chromatography B, 1996,687: 437-442
5 Elsom LF, Hawkins DR, Chasseaud LF. Identification of a major metabolite of the new hypolipidaemic agent , isopropyl 2[4′(pchlorobenzoyl ) phenoxy]2methylpropionate(procetofene) in humans by gas chromatographymass spectrometry[J].J Chromatogr, 1976, 123:463-466

资料来自:中国药师-专业站
参与评论(条评论)
发表评论请遵守国家法律
笔名:
邮箱:
查看评论

搜索
请输入关键词:
网上调查
相关资源
  • 格列美脲口腔崩解片人体药动学及相对生物利用度-06.12 [2007-2-1]
  • 盐酸伐昔洛韦在健康志愿者体内的生物等效性-06.10 [2007-1-17]
  • 奥美拉唑肠溶胶囊的人体药动学及生物等效性-06.10 [2007-1-17]
  • 联用非诺贝特和坎地沙坦改善甘油三酯和血压 [2006-3-1]
  • 非诺贝特可降低糖尿病患者发生心血管疾病的风险 [2005-11-16]
  • FDA批准非诺贝特水溶性新剂型 [2005-6-1]
  • 非诺贝特可减慢糖尿病人微白蛋白尿症 [2005-3-28]